Literature DB >> 32135185

RETRACTED: Methyltransferase-like 1 (METTL1) served as a tumor suppressor in colon cancer by activating 7-methyguanosine (m7G) regulated let-7e miRNA/HMGA2 axis.

Yang Liu1, Yusheng Zhang1, Qiang Chi1, Zhen Wang1, Boshi Sun2.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Concern was raised by a reader that the pictures of different cell lines in Fig. 3A and Fig. 4D were from the same cell line, suggesting repeated use of the same picture. The editor contacted the corresponding author for explanation, but there was no reply. Apologies are offered to readers of the journal that this was not detected during the submission process.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  7-methyguanosine; Colon cancer; HMGA2; Let-7e miRNA; Methyltransferase-like 1

Mesh:

Substances:

Year:  2020        PMID: 32135185     DOI: 10.1016/j.lfs.2020.117480

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   6.780


  24 in total

1.  N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma.

Authors:  Binbin Chen; Wei Jiang; Ying Huang; Jian Zhang; Peng Yu; Lirong Wu; Hao Peng
Journal:  Oncogene       Date:  2022-02-26       Impact factor: 9.867

Review 2.  METTLing in Stem Cell and Cancer Biology.

Authors:  John G Tooley; James P Catlin; Christine E Schaner Tooley
Journal:  Stem Cell Rev Rep       Date:  2022-09-12       Impact factor: 6.692

3.  Expression and Potential Biomarkers of Regulators for M7G RNA Modification in Gliomas.

Authors:  Zhen Chen; Zhe Zhang; Wei Ding; Jie-Hui Zhang; Zi-Long Tan; Yu-Ran Mei; Wei He; Xiao-Jing Wang
Journal:  Front Neurol       Date:  2022-05-09       Impact factor: 4.086

4.  Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures.

Authors:  Fei Lu; Jingyan Gao; Yu Hou; Ke Cao; Yaoxiong Xia; Zhengting Chen; Hui Yu; Li Chang; Wenhui Li
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

5.  A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma.

Authors:  Peng Hong; Huifang Du; Ming Tong; Qingfei Cao; Ding Hu; Jiaji Ma; Yanyang Jin; Zizhi Li; Weichao Huang; Guangquan Tong
Journal:  Front Genet       Date:  2022-06-24       Impact factor: 4.772

Review 6.  Novel roles of METTL1/WDR4 in tumor via m7G methylation.

Authors:  Wenli Cheng; Aili Gao; Hui Lin; Wenjuan Zhang
Journal:  Mol Ther Oncolytics       Date:  2022-06-07       Impact factor: 6.311

7.  A bioinformatic analysis study of m7G regulator-mediated methylation modification patterns and tumor microenvironment infiltration in glioblastoma.

Authors:  Xinrui Wu; Chuanyu Li; Zhisu Wang; Yundi Zhang; Shifan Liu; Siqi Chen; Shuai Chen; Wangrui Liu; Xiaoman Liu
Journal:  BMC Cancer       Date:  2022-07-04       Impact factor: 4.638

Review 8.  N6-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction.

Authors:  Jinming Li; Lei Liang; Yongzhi Yang; Xinxiang Li; Yanlei Ma
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 9.  Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers.

Authors:  Dawei Rong; Guangshun Sun; Fan Wu; Ye Cheng; Guoqiang Sun; Wei Jiang; Xiao Li; Yi Zhong; Liangliang Wu; Chuanyong Zhang; Weiwei Tang; Xuehao Wang
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-01       Impact factor: 8.886

10.  METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation.

Authors:  Esteban A Orellana; Qi Liu; Eliza Yankova; Mehdi Pirouz; Etienne De Braekeleer; Wencai Zhang; Jihoon Lim; Demetrios Aspris; Erdem Sendinc; Dimitrios A Garyfallos; Muxin Gu; Raja Ali; Alejandro Gutierrez; Sigitas Mikutis; Gonçalo J L Bernardes; Eric S Fischer; Allan Bradley; George S Vassiliou; Frank J Slack; Konstantinos Tzelepis; Richard I Gregory
Journal:  Mol Cell       Date:  2021-08-04       Impact factor: 19.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.